Carthera
Founded 2010 · 1 known investors
Carthera develops the SonoCloud implantable device, which uses low intensity pulsed ultrasound and infused gas microbubbles to temporarily and reversibly open the blood-brain barrier. The technology aims to improve delivery of chemotherapies, immunotherapies, and other agents to the brain for treating brain cancers such as gliomas and other brain diseases.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Carthera do?
- Carthera develops the SonoCloud implantable device, which uses low intensity pulsed ultrasound and infused gas microbubbles to temporarily and reversibly open the blood-brain barrier. The technology aims to improve delivery of chemotherapies, immunotherapies, and other agents to the brain for treating brain cancers such as gliomas and other brain diseases.
- Who are Carthera's investors?
- Carthera's investors include Supernova Invest.